NYSE$CNC

Centene Corp · Q3 2020 earnings

Q3 2020 earnings · · Investor relations

Briefing

Centene reported strong third quarter results, marked by significant revenue growth and strategic reinvestments.

Centene Corporation reported a 53% increase in total revenues to $29.1 billion for the third quarter of 2020, driven by the WellCare acquisition and expansions. GAAP diluted EPS was $0.97, and adjusted diluted EPS was $1.26. The company is reinvesting a one-time risk corridor settlement into growth initiatives.

  • Managed care membership reached 25.2 million, a 65% increase year-over-year.
  • Total revenues grew by 53% to $29.1 billion compared to Q3 2019.
  • Health benefits ratio (HBR) was 86.4%, a decrease from 88.2% in Q3 2019.
  • Diluted EPS was $0.97, compared to $0.23 in the third quarter of 2019.

Headline financials

Total Revenue

$29.1B

Previous: $19B+53.3%
EPS (adj)

$1.26

Previous: $0.96+31.3%
SG&A expense ratio

9.1%

Previous: 8.9%+2.2%
Adjusted SG&A ratio

8.9%

Previous: 8.8%+1.1%
Days in claims payable

52

No prior period
Capital Expenditures

-$663M

Previous: -$530M-25.1%
Free Cash Flow

-$95M

Previous: -$435M+78.2%
Net Income

$568M

Previous: $95M+497.9%
Operating Income

$861M

Previous: $176M+389.2%
Gross Profit

$28.2B

Previous: $18.4B+53.8%
Cash & Equivalents

$12.2B

Previous: $6.22B+96.3%
Total Assets

$68.4B

Previous: $34.3B+99.6%
Stock-Based Comp

$54M

Previous: $34M+58.8%

Revenue & EPS history

Centene · Revenue · Quarterly

$29.1B

Q3 2020+53.3%vs Q3 2019
Beat estimate in 13 of 16 quarters(81%)
ActualEstimate

Revenue by segment

Centene · $28.5B total across 4 segments · Q3 2020

  • Medicaid
    $19B
  • Commercial
    $4.64B
  • Medicare
    $3.6B
  • Other
    $1.24B

Forward guidance

The Company's annual adjusted diluted EPS guidance has been increased by $0.12 to reflect the favorable tax settlement recorded in the third quarter.

Tailwinds

  • Total revenues (in billions) $109.8 - $111.4
  • GAAP diluted EPS $3.22 - $3.32
  • Adjusted diluted EPS $4.90 - $5.06
  • Reflects tightening of guidance range.
  • The Company's annual adjusted diluted EPS guidance has been increased by $0.12 to reflect the favorable tax settlement recorded in the third quarter.

Headwinds

  • Estimated amortization of acquired intangible assets of $0.93 to $0.95 per diluted share
  • Acquisition related expenses of $0.68 to $0.72 per diluted share
  • The gain on the sale of the Illinois health plan of approximately $0.10 per diluted share
  • Debt extinguishment costs of approximately $0.07 per diluted share
  • Non-cash asset impairment of $0.10 per diluted share

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q3 2020

Historical avgQ3 2020

+0.4%

Avg return

Earnings day

+0.4%

Avg return

5 days after

+1.9%

Avg return

30 days after

54%

37 / 68 earnings

Positive

+13.8%

Q1 2014

Best reaction

-10.4%

Q2 2016

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+0.5%+22.6%+33.9%
Q4 2025-3.7%+1.3%+9.3%
Q3 2025+12.5%+3.9%+18.5%
Q1 2025-6.3%-2.8%-8.4%
Q4 2024-5.4%-9.1%-8.3%
Q3 2024+0.0%+0.3%-2.0%
Q2 2024+9.0%+14.1%+16.5%
Q1 2024-2.4%-4.5%-1.4%
Q4 2023+1.1%+4.4%+7.5%
Q3 2023-3.0%-4.8%+4.7%
Q2 2023-2.7%-3.7%-9.2%
Q1 2023-1.5%+1.9%-6.3%
Q4 2022+2.7%+2.4%-7.7%
Q3 2022+11.9%+13.2%+10.3%
Q2 2022+0.6%+1.1%+4.1%
Q1 2022-4.9%-5.1%-3.5%
Q4 2021+6.4%+3.1%+4.5%
Q3 2021+3.8%+4.8%+11.2%
Q2 2021-4.0%-5.6%-12.5%
Q1 2021-9.9%-6.5%+11.7%
Q4 2020+4.8%+1.6%+6.3%
Q3 2020-7.9%-11.0%-6.3%
Q2 2020-1.4%-3.0%-10.1%
Q1 2020-6.6%-8.3%-5.5%
Q4 2019+5.1%+0.4%-5.0%
Q3 2019+5.7%+5.4%+30.4%
Q2 2019+3.0%+2.4%-12.7%
Q1 2019+4.4%+9.5%+15.3%
Q4 2018-2.9%-3.2%-13.2%
Q3 2018-8.3%-9.9%-5.5%
Q2 2018-3.1%-3.0%+6.0%
Q1 2018-1.2%-0.4%+5.5%
Q4 2017+5.0%+2.3%+0.9%
Q3 2017-7.4%-3.7%-1.1%
Q2 2017-1.0%-1.8%+2.1%
Q1 2017+1.1%+3.3%+4.5%
Q4 2016+7.9%+9.1%+9.3%
Q3 2016+1.4%+0.1%-10.5%
Q2 2016-10.4%-6.3%-10.0%
Q1 2016+4.2%
Q4 2015+2.2%
Q3 2015+5.3%
Q2 2015+0.2%
Q1 2015-9.7%
Q4 2014+5.6%
Q3 2014+9.3%
Q2 2014+5.8%
Q1 2014+13.8%
Q4 2013+4.5%
Q3 2013-4.1%
Q2 2013+5.1%
Q1 2013+4.4%
Q4 2012+6.1%
Q3 2012+0.3%
Q2 2012+6.9%
Q1 2012-6.0%
Q4 2011-2.5%
Q3 2011+12.6%
Q2 2011+3.3%
Q1 2010+10.9%
Q1 2011+2.4%
Q4 2008-6.5%
Q4 2010-6.5%
Q3 2009-6.6%
Q2 2009-6.6%
Q3 2010-6.6%
Q4 2009-5.3%
Q2 2010-5.3%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro